Treatment of rheumatoid arthritis by immunization with mononuclear white blood cells: Results of a preliminary trial

Journal of Rheumatology

Volumn 23, Issue 2, 1996, Pages 220-225

  Smith, J Bruce ^a   Fort, John G ^a  

^a Department of Medicine ^*  (United States)

Author keywords

MNC immunotherapy; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNIZATION; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0030000365     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Persellin RH: The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1976;17:922-1.
2. Lohse AW, Bakker NPM. Hermann E, Poralla T, Jonker M, Meyer zum Buschenfelde KH: Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans. J Autoimmunity 1993;1:121-30.
3. Hazes, JMW, Dijkmans BAC, Vandenbroucke JP, deVries RRP, Cats A: Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum 1990:33:1110-5.
4. Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA: Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1991;329:466-71.
5. Redman CWG, Arenas J, Mason DY, Sargent IL, Sutton L: Maternal alloimmune recognition of the fetus in human pregnancy. In: Gill TJ Jr, Wegmann TG, eds. Immunoregulation and Fetal Survival New York: Oxford University Press, 1987:210-29.
6. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
7. Felson DT, Andersen JJ, Boers M. et al: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1991;36:729-40.
8. Welch HG, Meehan KR, Goodnough LT: Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992;116:393-402.
9. Smith JB, Cowchock FS: Immunological studies in recurrent spontaneous abortion: Effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome. J Reprod Immunol 1988;14:99-113.
10. Coulam CB, Clark DA, Collins J, Scott JR, Schlesselman JS: Worldwide collaborative observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion Am J Reprod Immunol 1995;32.55-12
11. Kingsley GH, Verwilghen J: T cell vaccination in humans. Clin Exp Rheumatol 1993;11:563-364
12. van Laar JM, Miltenburg AMM, Verdonk MJA. et al: Effects of innoculation with attenuated autologous T cells in patients with rheumatoid arthritis. J Autoimmunity 1993,6:159-67.
13. Sany J, Clot J, Bonneau M, Andary M. Immunomodulating effect of human placenta-eluted gamma globulins in rheumatoid arthritis. Arthritis Rheum 1982;25:11-24.
14. Tumiati B, Casoh P, Veneziani M, Rinaldi G: High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis. Arthritis Rheum 1992;35:1126-33.
15. Morris PJ, Wood KJ, Dallman MJ: Antigen-induced tolerance to organ allografts. Ann NY Acad Sci 1991;636:295-305.
16. Lowry RP, Takeuchi T. Immunologic tolerance and its relationship to clinical transplantation. In: Burdick JE Racusen LC, Solez K, Williams GM, eds. Kidney Transplant Rejection: Diagnosis and Treatmem. New York: Marcel Dekker, 1992:83-233.
17. Taylor CG, Faulk WP: Prevention of recurrent miscarriage with leukocyte immunization. Lancet 1981;2:68-9.
18. Salgame P, Convit J, Bloom BR: Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci USA 1997;88:2598-602.
19. Gao X, Olsen NJ, Pincus T, Stastny P: HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum 1990;33:939-46.
20. Nelson JL, Dugowson KE, Koepsell TD, et al: Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis. Arthritis Rheum 1994;37:673-80.
21. Mosmann TR. Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
22. van der Pouw-Kraan T, De Jong R, Aarden L: Development of human Th1 and Th2 cytokine responses: The cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur J Immunol 1993;23:1-5
23. Dayer J-M, Demczuk S: Cytokines and other mediators in rheumatoid arthritis. Springer Semin Immunopathol 1984;7:387-413.
24. Chin JE, Winterrowd GE, Krzesicki RF, Sanders ME: Role of cytokines in inflammatory synovitis: The coordinate regulation of intercellular adhesion molecule I and HLA class I and class II antigens in rheumatoid synovial fibroblasts. Arthritis Rheum 1990;33:1776-86.
25. Katsikis PD, Chu C-Q, Brennan FM, Maim RN, Feldmann M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
26. Pearlman SA, Meek RS, Cowchock FS, Smith JB, McFarland J, Aster RH: Neonatal alloimmune thrombocytopenia after maternal immunization with paternal mononuclear cells: Successful treatment with intravenous gamma globulin. Am J Perinatol 1992,9:448-51.
27. Fries JF, Williams CA, Ramey D, Bloch DA: The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 1993;36:297-306.
28. Trentham DE: New focus on treatment for rheumatoid arthritis. Curr Opin Rheumatol 1993;5:178-83.
29. Pincus T, Callahan LF: Taking mortality in rheumatoid arthritis seriously. Predictive markers, socioeconomic status and comorbidity. J Rheumatol J 1986;13 841-5.
30. Scott DL, Symmons DPM, Coulton BL, Popert AJ: Long-term outcome of treating rheumatoid arthritis: Results after 20 years. Lancet 1987;1:1108-11.
31. Erhardt CC, Mumford PA, Venables PJW, Maini RN: Factors predicting poor life prognosis in rheumatoid arthritis: An eight year prospective study. Ann Rheum Dis 1989;48:7-13.
32. Wolfe F, Mitchell DM, Sibley JT. et al: The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94